模拟一项随机临床试验与现实世界的数据来评估使用抗抑郁药物对高自杀风险的PTSD患者的影响
Oshin Miranda1, Xiguang Qi1, M Daniel Brannock2
1Department of Pharmaceutical Sciences/School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States.
Frontiers in psychiatry
|February 12, 2025
概括
对于具有高自杀风险的创伤后应激障碍 (PTSD) 患者来说,西塔洛普拉姆可能是一个更安全的抗抑郁药选择,与其他常见抗抑郁药相比,与自杀相关的事件较少.
科学领域:
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
背景情况:
- 创伤后应激障碍 (PTSD) 与行为变化和自杀风险增加有关.
- 对于治疗自杀风险较高的PTSD患者的最佳抗抑郁药物没有确立的共识.
研究的目的:
- 为了比较与自杀相关事件 (SREs) 的发生率,在开始服用不同抗抑郁药的PTSD患者中.
- 在这个脆弱人群中确定与特定抗抑郁药相关的潜在风险.
主要方法:
- 采用了临床试验模拟研究设计.
- 在合格的SRE后60天内开始服用抗抑郁药的患者进行了跟踪.
- 主要结果是出现新的SRE.
主要成果:
- 与文拉法辛,杜洛克赛丁和米尔塔扎相比,西塔洛普拉姆的新SRE显著减少.
- 经过多次比较和共变量调整后,这些发现仍然具有意义.
结论:
- 奇塔洛普拉姆可能是高自杀风险的PTSD患者更安全的治疗选择.
- 由于潜在的差异性风险,处方者在为PTSD患者选择抗抑郁药时应谨慎行事.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
183
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
183
01:30Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22